
Galmed Pharmaceuticals (GLMD) Stock Forecast & Price Target
Galmed Pharmaceuticals (GLMD) Analyst Ratings
Based on 13 analyst ratings
Buy
Strong Buy 69%
Buy 15%
Hold 15%
Sell 0%
Strong Sell 0%
Galmed Pharmaceuticals (GLMD) has been analyzed by 13 analysts, with a consensus rating of Buy. 69% of analysts recommend a Strong Buy, 15% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Galmed Pharmaceuticals and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Galmed Pharmaceuticals and is not a guaranteed prediction by Public.com or investment advice.
Galmed Pharmaceuticals (GLMD) Analyst Forecast & Price Prediction
Get the latest Galmed Pharmaceuticals (GLMD) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Galmed Pharmaceuticals (GLMD)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Galmed Pharmaceuticals (GLMD) Forecast
Analysts have given Galmed Pharmaceuticals (GLMD) a Buy based on their latest research and market trends.
According to 13 analysts, Galmed Pharmaceuticals (GLMD) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $16.54, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $16.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.